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Noninvasive measurement of myocardial blood flow in 
absolute terms (i.e., milliliters per gram per min) has been 
difficult to accomplish despite the intrinsically quantitative 
power of positron emission tomography because of the 
nonphysiologic nature of tracers that have been employed 
conventionally as well as tbe limited spatial resolution of 
currently available instruments. It was previously demon- 
strated that myocardial blood flow in animals can be 
quantitated accurately with the diffusible tracer oxygen- 
&labeled water (H,“O) when the arterial input function 
and myocardial radiotracer concentration were measured 
directly. To extend the approach for completely noninva- 
sive measurement of blood flow, a parameter estimation 
procedure was developed whereby effects of limited tomo- 
graphic spatial resolution and cardiac motion were com- 
pensated for within the operational flow model. 
In validation studies in 18 dogs, myocardial blood flow 
measured with positron emission tomography after intra- 
venously administered H,“O correlated closely with Bow 
measured with concomitantly administered radiolabeled 
microspheres over the range of 0.29 to 5.04 ml/g per min 
(r = 0.95). Although regional ischemia was clearly ldenti- 
liable tomographically, absolute flow could not be deter. 
mined accurately in ischemic regions in four dogs because 
of poor count statistics related to wall thinning. Subse- 
quently, myocardii blood flow was measured in 11 normal 
human subjects. Flow was homogeneous throughout the 
myocardium, averaged 0.90 + 0.22 ml/g per min at rest 
and increased to 3.55 2 1.15 ml/g per min after intravenous 
administration of dipyridamole. 
Therefore, positron emission tomography with H,“O 
and the approach developed permits noninvasive measure. 
ment of myocardial blood flow in absolute terms in humans 
and should facilitate objective assessment of interventions 
designed to enhance nutritive perfusion. 
(J Am Co11 Cardiol1989;14:639-52) 
Measurement of myocardial blood flow is of paramount 
importance for evaluation of the functional significance of 
coronary artery disease and for assessment of effects of 
therapeutic interventions, such as thrombolytic therapy, 
balloon angioplasty and coronary artery bypass surgery, on 
nutritional perfusion. However, quantitation of myocardial 
blood flow in absolute terms with noninvasive techniques 
From the Cardiovascular Division, Department of Internal Medicine, 
Washington University School of Medicine, St. Louis, Missouri. This study 
was supported in part by Grant HLl7646 from the National Institutes of 
Health, and Specialized Center of Research in lschemic Heafl DiPease, 
Bethesda, Maryland. This work was presented in part at the 61st Scientific 
Sessions of the American Heart Association, Washington. D.C., November 
1988. 
Manuscript received August 15. 1988: revised manuscript received De- 
cember 29, 1988, accepted February 21, 1989. 
&&&QJ remintg: Steven R. Bergmann, MD, PhD, Cardiovascular 
Division, Washington University School of Medicine, Box 8086, 660 South 
Euclid Avenue, St. Louis, Missouri 631 IO. 
01989 by the American College of Cardiology 
has been hampered by instrumentation limitations and by the 
non-physiological nature of tracers conventionally used (1). 
We and others have previously demonstrated that myo- 
cardial blood flow can be measured accurately in intact dogs 
with radiolabeled water with use of a one-compartment 
mathematical model when the arterial input function and 
tissue radioactivity are measured directly (2,3). Oxygen- 
154abeled water (H,lSO) has several advantages as a 
positron emitting tracer for measurement of blood flow 
compared with other tracers such as nitrogen (N)-13 ammo- 
nia or rubidium-82. Myocardial uptake and retention of 
cationic tracers are dependent on active processes and 
affected by the metabolic status of the myocardium (1,4-12). 
In addition, recent studies (13) indicate that N-13 ammonia is 
rapidly converted to metabolic intermediates after intrave- 
nous administration further complicating estimates of blood 
flow with this tracer. In contrast, radiolabeled water is a 
diffusible tracer. Its myocardial kinetics appear to be related 
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solely to flow and are not altered by changes in metabolism 
(2,3). In addition, the short physical half-life of oxygen-15 
@l/2 = 2.1 min) permits rapid sequential evaluations of 
myocardial blood flow with only modest radiation exposure 
to the subject. 
In previous laboratory and clinical studies (2,1C17), we 
demonstrated the utility of noninvasive measurement of the 
regional distribution of H,150 (i.e., relative tracer content in 
abnormal compared with normal myocardium). In studies in 
animals (2,15,16), we correlated these regional differences 
with absolute flow. However, totally noninvasive quantifi- 
cation of myocardial blood flow with H,150 has been difficult 
to achieve because of the need to measure tissue radiotracer 
concentration in absolute terms. 
Positron emission tomography is an intrinsically powerful 
quantitative imaging tool that provides noninvasively ac- 
quired, three-dimensional reconstructions of the distribution 
of positron emitting radiotracers within an organ of interest. 
However, accurate measurement of the concentration of 
tracers within the heart, necessary for assessment of myo- 
cardial blood flow and metabolism in absolute terms with the 
use of appropriate mathematical models, is complicated by 
cardiac motion (l&19) and by the limited spatial resolution 
of available tomographic systems in relation to the dimen- 
sion of the myocardial wall imaged (20), in addition to factors 
such as inaccurate random and photon attenuation correc- 
tions and the path length of positrons in tissue before 
annihilation (1). Interrogation of regions ~2 times the full 
width at half maximal resolution of the tomograph used 
results in partial volume effects (underestimation of true 
radiotracer concentration) and spillover (contamination of 
activity in one region with that from an adjacent one) (20). 
These effects as well as effects of cardiac motion present 
particularly difficult problems. 
Solutions have been proposed to correct for effects of 
cardiac motion (18,191 and of partial volume and spillover 
e$ects (21). However, they have not been employed gener- 
ally because of the complexity of their implementation and 
because of the additional practical problems that their use 
engenders. For example, use of electrocardiographic gating 
to reduce motion artifact decreases the amount of data 
collected per cardiac cycle, thereby decreasing signal to 
noise ratios. Henze et al. (21) proposed a valuable approach 
to correct for partial volume and spillover effects when the 
performance characteristics of the individual tomograph 
used and myocardial wall thickness and left ventricular 
cavity dimensions are known. Then, four correction factors 
(FBB 7 the recovery coefficient of radioactivity in the left 
ventricular chamber: F,,, the fraction of radioactivity spill- 
ing over from the cavity into the myocardium; F,,, the 
recovery coefficient of radioactivity in myocardium; and 
F,,, the fraction of radioactivity spilling from myocardium 
into blood) can be calculated and used to estimate true 
radiotracer concentrations from observed count data. Al- 
though we confirmed the accuracy of this approach (22) and 
showed that it can be employed successfully for measure- 
ment of myocardial blood flow in absolute terms using 
H,“O, the fact that the dimensions of the heart must be 
known accurately introduces a serious logistic limitation for 
clinical use. 
Because sufficiently accurate measurements of cardiac 
dimensions cannot be made directly with positron emission 
tomography, they must be obtained with a second modality 
such as echocardiography, nuclear magnetic resonance im- 
aging or ultrafast X-ray computed tomography. Dual modal- 
ity imaging is not practical for routine use. Also, it is difficult 
to assure that interrogation of the myocardium has been 
accomplished in the same anatomic planes with both modal- 
ities. Intrinsic difficulties in measuring myocardial cavity 
diameter and wall thickness at different times occur because 
ventricular loading conditions can change rapidly, especially 
in the setting of acute cardiac events. In addition, relatively 
modest errors in measured wall thickness or cavity diameter 
assignments can lead to substantial errors in the estimates of 
radiotracer concentration and therefore myocardial blood 
flow (Appendix). Unless cardiac and respiratory gating are 
employed, the procedure proposed by Henze et al. (21) does 
not account for effects of cardiac motion on quantitation of 
radiotracer concentrations. 
Recently, Iida et al. (23) used a kinetic model for mea- 
surement of myocardial blood flow with H,150 that corrects 
for partial volume effects and presented promising data in a 
small number of human subjects. However, the approach 
developed was not validated by an independent measure- 
ment of myocardial blood flow. In addition, effects of 
spillover of H,“O from the blood pool into the myocardium 
were corrected with the use of independent measurement of 
blood volume with oxygen-&labeled carbon monoxide 
(C”O) and a subtraction technique that can lead to errors, 
especially if the patient moves between scans (17,24). 
In the present study, we report a mathematical model 
coupled with the use of H,“O and positron emission tomog- 
raphy that is designed to overcome the limitations of previ- 
ous correction schemes. The approach employs parameter 
estimation to correct for partial volume and spillover effects 
as well as to account for the influence of motion. Once we 
had demonstrated that use of this novel correction scheme 
led to accurate estimates of myocardial blood flow in studies 
in experimental animals, we applied it to 11 normal human 
volunteers. 
Methods 
Validation Studies in Dogs 
All studies in experimental animals were performed under 
general anesthesia and conformed to the “Position of the 
American Heart Association on Research Animal Use.” 
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Experimental preparation. Eighteen mongrel dogs were 
sedated with I mg/kg body weight of morphine subcutane- 
ously after an overnight fast and anesthetized with 12.5 
mgikg of thiopental and 60 mg/kg of alpha-chloralose admin- 
istered intravenously. The dogs were intubated and venti- 
lated with room air. Ten dogs without coronary instrumen- 
tation were studied at rest, after coronary hyperemia 
induced with intravenous dipyridamole or after global low 
flow. In five other intact dogs, regional ischemia was in- 
duced. Thrombosis was initiated in the left anterior descend- 
ing coronary artery with an intracoronary copper coil as 
described previously (25). In three additional intact dogs, 
coronary stenosis of 50% to 70% diameter narrowing was 
induced by placement of an intracoronary plastic stenosis in 
the left anterior descending coronary artery after anticoagu- 
lation with 500 U/kg heparin intravenously as described 
previously (IS). 
To evaluate a wide range of pow, in some studies 
myocardial hyperemia was induced with intravenous dipyr- 
idamole (a gift of Boehringer-Ingleheim) infused at a dose of 
0.15 mg/kg per min for 4 min. After a 4 to 5 min delay, 
estimates of flow were made. To characterize low flow 
without regional wall thinning otherwise induced by coro- 
nary occlusion, global low flow was induced in three dogs by 
treatment with propranolol (2 mg/kg intravenously) and 
hypotension (systolic pressure <40 mm Hg) induced by 
hemorrhage of 50% of calculated circulatory blood volume 
and intravenous nitroprusside. 
Tomographic procedure. Dogs were placed in a plexi- 
glass shell and positioned within PETT VI, a positron 
emission tomograph designed for clinical neurologic studies, 
and permitting the simultaneous acquisition of seven trans- 
verse tomographic slices with a slice to slice distance of 1 A4 
cm and a slice thickness of 1.39 cm (26). A transmission 
scan, necessary for attenuation correction. was obtained 
with use of an external ring of germanium-68igallium-68. To 
permit delineation of the blood pool, dogs inhaled 20 to 40 
mCi of Cl50 to label red blood cells in vivo. After a 30 s 
delay to allow residual C”O to clear the lungs, emission 
data, collected in the high resolution mode, were acquired 
for 5 min. After completion of the Cl50 data collection, 5 
additional min were allowed for the decay of the oxygen-15. 
Then, 20 to 30 mCi of H,i50 was administered intravenously 
as a bolus over 3 to 5 s. Tomographic acquisition was 
initiated at the time of administration of the H2150 bolus and 
continued for 90 s. Data were processed in 5 s frames. 
In preliminary studies we determined that, in dogs, in 
contrast to data recently reported by Weinberg et al. (27) and 
in agreement with data from Henze et al. (21), the arterial 
input function could not be accurately obtained noninva- 
sively from a region of interest placed in the blood pool in 
reconstructed images because of resolution limitations com- 
bined with the influence of cardiac and respiratory motion. 
Therefore, in dogs, the arterial input function was obtained 
by monitoring the time-activity curve from a catheter exte- 
riorized from the thoracic aorta by way of the femoral artery. 
Radioactivity was detected with a collimated scintillation 
probe and data were acquired on a minicomputer for subse- 
quent analysis. The collimation provided complete shielding 
from activity within the experimental animal. Comparisons 
between time-activity curves defined by the probe and data 
obtained by direct sampling of blood were excellent (unpub- 
lished observations). Use of the directly measured input 
function in dogs obviated the need for correcting blood 
counts for recovery coefficient (Fau) or for myocardial to 
blood spillover (F,n). 
Measurement of blood flow with radiolabeled micro- 
spheres. The results of measurement of blood flow obtained 
with positron emission tomography were compared with 
those obtained with radiolabeled 15 pm microspheres admin- 
istered through a retrogradely placed left atria1 catheter 
immediately at the completion of each data collection from 
H,“O. While microspheres were administered, blood from a 
femoral artery was withdrawn with a constant withdrawal 
pump. After the dogs had been killed with an overdose of 
anesthesia and saturated potassium chloride intravenously, 
10 to 20 transmural samples (approximately 1 g each) of 
myocardium from the anterior left ventricle (i.e., distal to the 
left anterior descending coronary artery stenosis or coil in 
those dogs subjected to those procedures), and 8 to 12 
samples from normal posterolateral myocardium were ob- 
tained. Regions were selected to correspond with large 
regions of interest readily identifiable from the reconstructed 
positron emission tomography images. Blood flow was cal- 
culated with the standard microsphere reference technique 
(28). 
Human Studies 
The protocol was approved by the Washington Univer- 
sity Institutional Review Board (Human Studies Committee) 
on June 8, 1983. The nature of the study was explained to 
each subject and written informed consent was obtained. 
Study subjects. All subjects (5 male, 6 female with a mean 
age of 25.5 years, evaluated consecutively) were without 
history or symptoms suggestive of coronary artery disease. 
Subjects did not fast but refrained from oral intake of methyl 
xanthines (including caffeine) on the day of the study so as 
not to attenuate effects of dipyridamole (29). Each was 
positioned in Super PETT I, a whole body time-of-flight 
positron emission tomograph that permits simultaneous ac- 
quisition of seven transaxial slices with a center to center 
slice separation of 1.5 cm and a slice thickness of 1.14 cm 
(30). Polyurethane molds were made individually for each 
subject before each study and used to stabilize the head, 
neck and upper torso of the subject so that movement 
between tomograms was minimized. A transmission scan of 
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Figure 1. Reconstructed tomographic 
images obtained in one study in a nor- 
mal human volunteer depicting the 
placement of regions of interest &thin 
the left atrium (LA) (unner left). left 
ventricle (LV) (upper right) and tho- 
racic aorta (AO) (lower left). These 
reconstructions were performed after 
the volunteer inhaled approximately 30 
to 40 mCi of oxygen-15 carbon monox- 
ide to label erythrocytes in vivo. Ante- 
rior is to the top, posterior is to the 
bottom, the subject’s left is to the right 
and the subject’s right is to the left. On 
the lower right of this figure, the re- 
gions of interest in the lateral (LAT.), 
anterior (ANT) and septal (SEP) myo- 
cardium as well as in the middle of the 
left ventricle are displayed in a tomo- 
gram obtained after administration of 
Ha”0 after correction for vascular ra- 
dioactivity. Images were used only for 
visualization of the myocardium and 
for placement of regions of interest and 
not used for quantitation of flow. 
the chest was obtained with an external ring of germanium- 
68/gallium-68 to correct for photon attenuation. 
Tomographic procedure. After collection of attenuation 
data, 0.4 mCi/kg of H,“O was injected as a bolus (over 3 to 
5 s) through a large bore catheter inserted into an antecubital 
vein. Data were collected in list mode in the high resolution 
mode beginning at the time of the initiation of the infusion. 
After a 5 min interval to allow decay of activity of the tracer 
to baseline levels, 40 to 50 mCi of Cl50 was administered by 
inhalation to label the blood pool. After a subsequent inter- 
val of 30 to 60 s to allow clearance of carbon monoxide from 
the lungs, data were collected for 5 min. After completion of 
data collection under baseline conditions, dipyridamole (Per- 
santine, supplied by Boehringer-Ingelheim), 0.14 mg/kg per 
min for 4 min (0.56 mg/kg total dose), was administered 
intravenously. After an interval of 4 min to permit develop- 
ment of peak responses of flow, the tomographic imaging 
sequence was repeated. 
Analysis of tomographic data. Tomographic data were 
reconstructed by filtered back projection (PETT VI) or 
confidence weighting (Super PETT I). For PETT VI, emis- 
sion data were reconstructed into 100 by 100 data point 
matrixes (400 by 400 pixels [picture elements]), with each 
data point representing 2.7 mm. The full width at half 
maxima1 resolution in reconstructed PETT VI images was 12 
mm. Super PETT I data were reconstructed into 128 by 128 
data point matrixes (384 by 384 pixels) with each data point 
representing 3.5 mm. The full width at half maximum in 
reconstructed Super PETT I images was 13.5 mm. 
Although arterial sampling to obtain the input function is 
feasible in human subjects, it is desirable to obtain the input 
function without the need for an arterial catheterization. In 
three patients (not included in the data analysis of this study) 
immediately after cardiac catheterization (in which a femoral 
artery sheath had been left in place and was used for direct 
sampling of arterial blood). the input function measured 
directly was compared with values obtained by analysis of 
tomographic reconstructions. In these patients, regions of 
interest representing volumes of approximately 3.5 cm3 (1.75 
X 1.75 cm area X slice thickness) were placed with the aid of 
the reconstructions obtained after inhalation of C”O in the 
left atrium, the left ventricle and the thoracic aorta (Fig. 1). 
Decay-corrected counts per data point obtained in one of 
these three patients from sequential 5 s tomographic recon- 
structions after the intravenous administration of H,150 
compared with directly sampled arterial counts are depicted 
in Figure 2. The left atria1 region of interest appeared to 
provide the most accurate and representative determination 
of the arterial input function. Subsequently, in the normal 
human subjects constituting the study group reported herein, 
the input function was obtained from the time-activity data 
in the left atria1 region of interest. This region was assumed 
to have a recovery coefficient (Fnn) of 100% and negligible 
spillover from myocardium (FM, = 0) based on results 
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Figure 2. Comparison of the input function obtained in a human 
subject from direct sampling from the femoral artery (solid line) 
(scaled to positron emission tomographic [PET] counts/pixel based 
on phantom studies) compared with noninvasive estimation by 
analysis of time-activity curves obtained in 5 s frames from regions 
of interest (ROI) placed in the left atrium, left ventricle or thoracic 
aorta. The time-activity curve obtained in the left atrium matched 
most closely with the input function sampled directly and was 
subsequently used for the input function. As is also depicted, the 
time-activity curve obtained from a region of interest within the left 
ventricle underestimates the peak arterial radiotracer concentration, 
and at times later than 30 s, is contaminated from spillover from the 
myocardium. The time-activity curve obtained from the region of 
interest within (he thoracic aorta underestimates peak arterial ra- 
diotracer concentration because of partial volume effects. 
obtained in experiments with phantoms (22) and on the 
anatomic size of these structures in transaxial tomographic 
reconstructions in humans. 
To obtain myocardial time-activity curves in tomographic 
reconstructions in both human and canine studies, three 
regions of interest representing 1.0 to 5.0 cm3 were interac- 
tively placed on one to two midventricular transverse tomo- 
graphic reconstructions (Fig. 1). The three regions placed 
represented anterior, septal and lateral myocardium. Be- 
cause HII labels both myocardium and blood, placement 
of myocardial regions of interest were performed with the 
aid of the scan corrected for vascular radioactivity as previ- 
ously described (2,17). Then, with unsubtracted H,“O 
scans, counts per data point were calculated from each 5 s 
frame for 90 s after appearance of HZ”0 in the left ventricle. 
Calculation of myocardial blood flow from positron emis- 
sion tomographic data. Myocardial blood flow in absolute 
terms was determined with a kinetic modification of the Kety 
one-compartment model (31-33). For calculation of flow, the 
input function, the time-activity profile of tracer in the 
myocardial tissue and the tissue/blood partition coefficient 
must be known. All data were corrected for isotope physical 
decay. In studies in animals, the arterial input measured 
directly was used. In human subjects, the input function 
obtained from analysis of the time-activity curve obtained 
from a left atrial region of interest was used. To correct 
observed myocardial time-activity curves for count recovery 
(FhlM). for radioactivity emanating in the ventricle and 
spilling into the myocardium (F& as well as for effects of 
motion, we estimated F,,, F,, as well as myocardial blood 
flow with a three parameter fitting technique developed for 
this purpose and described in detail in the Appendix. By 
including correction for partial volume, spillover and motion 
effects within the mathematical model for estimation of 
myocardial blood flow, no a priori knowledge of F,, and 
F nM is needed, avoiding errors associated with estimates 
and use of these parameters measured independently with 
other approaches. In addition, parameter estimates of F,, 
and F,, with our procedure incorporate the effects of 
motion, as well as any other factors that would tend to make 
observed counts deviate from true radiotracer concentra- 
tion. 
The tissuelblood partition coeficient used was 0.92 mllg 
for all studies. This value was derived previously (2). Al- 
though the true tissue/partition coeficient may change with 
changes in blood hematocrit as well as with myocardial 
injury, computer simulations have demonstrated that the 
flow model used is relatively insensitive to values of a 
tissue/blood partition coefficient from 0.8 to 1.0 (unpublished 
observations). 
Statistics. All data are presented as the mean values ? 
SD. For comparison of differences, the Student’s t test for 
independent or paired analysis, as appropriate, was em- 
ployed. Differences with a p value <O.OS were considered 
statistically significant. 
Results 
Measurement of arterial time-activity curves. in dogs, 
because of the small cardiac dimensions compared with the 
resolution of PETT VI and because of motion effects, 
recovery of count data in the blood pool (FBB) is < 100%. At 
intervals >20 to 30 s after administration of H,“O, blood 
pool activity is increased because of spillover from myocar- 
dium into blood. Therefore, for studies in animals, we 
sampled the arterial input function directly from a catheter 
placed in the thoracic aorta. 
In three human subjects, time-activity data obtained with 
positron emission tomography from a region of interest 
placed in the center of the left atrium. left ventricle and 
thoracic aorta were compared with the arterial time-activity 
curve obtained by direct arterial sampling after intravenous 
administration of H2150 (Fig. 2). In this limited number of 
comparisons, the time-activity data obtained from a region 
of interest placed within the left atrium appeared to agree 
most closely with the input function sampled directly. In 
addition, because the left atria1 blood pool in adult humans is 
>2 times the reconstructed full width at half maximal 
resolution of the tomograph used and because in transaxial 
reconstructions at the level of the left atrium there is minimal 
resoluble myocardial tissue that might cause myocardial to 
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blood pool spillover, we used the time-activity curve ob- 
tained from this region of interest to define the arterial input 
for all subsequent analyses in human volunteers. Time- 
activity data obtained from regions of interest placed within 
the left ventricle underestimated peak arterial tracer con- 
centration and at times >30 s appeared to overestimate 
arterial tracer concentration because of left ventricular 
myocardium to left ventricular blood pool spillover (FhIn) 
(Fig. 2). Time-activity data from a region of interest placed 
within the thoracic aorta significantly underestimated 
peak arterial radiotracer concentration because of partial 
volume effects but is not subjected to myocardial to blood 
spillover because it is sufficiently distant from myocardial 
regions (Fig. 1B). 
Tomographic estimates of myocardial blood flow in ani- 
maIs. Figure 3 depicts representative observed, fitted and 
model corrected time-activity curves obtained in dogs with 
the parameter estimation technique developed. In uncor- 
rected data, early after administration of H2150, tracer in the 
blood pool spills into myocardial regions of interest, thereby 
falsely elevating tissue radiotracer concentration values. At 
later intervals, this influence is decreased (although the 
spillover fraction is constant) because of diminished blood 
tracer concentration. 
Time-activity profiles were obtained over 90 s in each 
study. Myocardial blood flow was calculated with the model 
described in the Appendix and compared with measure- 
ments obtained with microspheres in control dogs at rest, or 
in dogs with coronary artery occlusion or stenosis studied at 
rest and after dipyridamole administration and in dogs with 
global low flow induced by hypotension. The correlation 
over the flow range of 0.29 to 5.04 ml/g per min determined 
with microspheres was 0.95 (Fig. 4). 
Determinations of flow in seven ischemic myocardial 
regions in four dogs (Table 1) could not be made (i.e., the 
model corrected tissue curves were too statistically inaccu- 
rate for parameters to be estimated with confidence). In 
these regions, microsphere-determined flow averaged 0.26 5 
0.14 ml/g per min and F,,, the myocardial recovery coef- 
ficient, averaged 0.20 t 0.08 (compared with an F,, of 0.65 
f 0.17 in normal regions at rest, p < 0.005) (Fig. 5). 
Because we previously demonstrated that myocardial 
blood flow could be measured accurately in ischemic regions 
with microsphere-determined flows of as low as 0.1 ml/g per 
min when H21S0 content was measured directly (2) we 
believed the inability to measure absolute flow in ischemic 
regions with positron emission tomography was most likely 
due to 1) the low number of true counts in the region as a 
result of ischemia; 2) decreased myocardial count recovery 
secondary to wall thinning (34); and 3) the greater influence 
of count spillover into ischemic, thinned regions from blood 
as well as from adjacent normal myocardium. To determine 
which effect was predominant, in three dogs we induced 
global low flow without regional ischemia using a combina- 
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Figure 3. Time-activity curves obtained in studies from a dog at 
rest (A), after intravenous dipyridamole (B) and during global low 
flow (C). In these figures the directly sampled arterial input function 
is depicted (Ca) (scaled to positron emission tomographic [PET] 
counts/pixel) as is observed tracer concentration in tissue (Cd. as 
well as the fitted line that best describes the discrete data (C, 
observed, fitted). Also depicted in the thin solid line (C,, corrected) 
is the parameter estimation model fitted curve incorporating correc- 
tion for spillover and partial volume effects as well as for cardiac 
motion (see text and Appendix). In this example, myocardial blood 
flow was calculated at 1 AlO, 3.75 and 0.37 ml/g per min, respectively, 
for the three curves. 
tion of hemorrhage, beta-blockade and peripheral vasodila- 
tion. In these animals, flow determined noninvasively aver- 
aged 0.27 -t 0.10 ml/g per mitt, agreeing closely with 
microsphere-determined flow (0.33 + 0.03 ml/g per min) 
(Table I, Fig. 5). In these dogs, F,, during low flow was 
0.74 t 0.18, suggesting that failure to calculate flow in 
ischemic regions manifesting wall thinning (reflected by a 
low F,,) was secondary to poor count statistics predomi- 
nantly related to wall thinning and was not model related. 
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Figure 4. Correlation between myocardial blood flow estimated by 
positron emission tomography (PET) and that obtained from con- 
comitantly administered radiolabeled microspheres in 18 dogs (37 
observations) showing the close correlation over the flow range from 
0.29 to 5.04 ml/g per min. 
Noninvasive assessment of myocardial blood flow in human 
subjects. Myocardial blood flow was determined in the 11 
normal human volunteers at rest and again after intravenous 
administration of dipyridamole. During the baseline study, 
heart rate and blood pressure of all 1 I subjects averaged 67 
+ 11 beats/min and 112 + 9/76 5 5 mm Hg, respectively. 
During the scan obtained after intravenous dipyridamole. 
heart rate increased to 90 +- 12 beats/min, and blood pressure 
was 119 ? I1170 ‘- 7 mm Hg (p < 0.025 for each compari- 
son). 
Figure 6 depicts time-activity curves obtuined in one 
study. At rest, myocardial blood flow in all subjects averaged 
0.90 t 0.22 mVg per min (Table 2). In 10 of the 11 subjects 
evaluated, after intravenous dipyridamole, myocardial blood 
flow increased by an average of 435 + 84%. In one subject 
(Case 7), myocardial blood flow increased only 20% after 
dipyridamole (Fig. 7, Table 2). Regional myocardial blood 
flow was homogeneous at rest, and increased uniformly after 
dipyridamole (Fig. 8). 
Discussion 
Accuracy of myocardial blood flow measurements with 
positron emission tomography. Measurement of myocardial 
blood flow is of importance for studies of normal human 
physiology as well as for characterization of changes in flow 
with cardiac disease and for assessment of effects of inter- 
ventions designed to improve myocardial perfusion (35,36). 
We previously demonstrated the feasibility and utility of 
assessing relative myocardial blood flow ratios in both 
animal and clinical studies (2,lb17). However, realization 
of the full potential of positron tomography for absolute 
quantitation of myocardial blood flow requires correction for 
partial volume, spillover and motion effects (1). 
Table 1. Estimates of Myocardial Blood Flow (MBF) With the 
Noninvasive Approach Developed Compared With Blood Flow 
Determined With Microspheres (MSBF) in the Study Dogs 
Study Group SCAN REG F,, Far+, MBF MSBF 
COlltrOlS 
1 Rest 
2 Rest 
3 Rest 
4 Rest 
5 Rest 
Rest 
6 Dipyr 
7 Dipyr 
Dipyr 
Coronary stenosis 
8 Rest 
Dipyr 
Rest 
Dipyr 
Y Rest 
Dipyr 
Rest 
Dipyr 
IO Rest 
Dipyr 
Rest 
Dipyr 
Coronary occlusion 
II Rest 
Rest 
12 
13 
14 
15 
Low flow 
16 
I7 
18 
Rest 
Dipyr 
R&t 
Dipyr 
Rest 
Dipyr 
Rent 
Dipyr 
Rest 
Dipyr 
Red 
Dipyr 
Rest 
Dipyr 
Rest 
Dipyr 
Low Row 
Rest 
Low flow 
Rest 
Norm 
Norm 
Norm 
Norm 
Norm 
Norm 
Norm 
Abn 
Abn 
Norm 
Norm 
Abn 
Abn 
Norm 
Norm 
Abn 
Abn 
Norm 
Abn 
Norm 
Norm 
Abn 
Abn 
Norm 
Norm 
Abn 
Abn 
Norm 
Abn 
Abn 
Norm 
Norm 
Abn 
Abn 
Norm 
Norm 
Norm 
Norm 
Low flow Norm 
0.82 0.15 1.50 1.32 
0.48 0.26 0.66 0.95 
0.66 0.14 0.87 0.98 
0.80 0.17 0.55 0.57 
0.94 0.11 1.04 1.00 
0.57 0.20 1.05 I .34 
0.83 0.15 3.48 3.33 
1.00 0.00 3.62 2.48 
0.95 0.00 5.25 5.04 
0.50 0.11 0.72 
0.99 0.20 1.37 
0.53 0.10 0.61 
0.82 0.22 0.86 
0.47 0.11 0.72 
0.63 0.04 2.35 
0.43 0.10 0.66 
0.60 0.04 2.48 
0.56 0.16 0.79 
I.41 0.07 2.86 
0.54 0.05 0.71 
0.88 0.04 1.34 
0.71 
1.30 
0.61 
0.83 
0.62 
2.40 
0.62 
1.56 
0.51 
I .79 
0.53 
0.89 
0.63 0.20 I .27 
0.57 0.30 0.76 
0.53 0.14 0.64 
I.10 0.03 2.22 
0.51 0.07 0.63 
0.18 0.02 * 
0.57 0.22 1.15 
0.66 0.10 1.89 
0.15 0.22 * 
0.10 0.19 * 
0.47 0.18 0.58 
0.73 0.22 1.89 
0.18 0.22 * 
0.18 0.27 * 
0.56 0.18 0.74 
0.95 0.10 3.40 
0.29 0.05 * 
0.32 0.12 * 
I.23 
0.52 
0.79 
2.62 
058 
0.17 
1.03 
1.98 
0.13 
0.08 
0.58 
I .98 
0.35 
0.27 
0.55 
2.X 
0.36 
0.47 
0.55 0.14 0.37 0.35 
0.92 0.13 0.42 0.62 
0.78 0.18 0.17 0.35 
0.88 0.19 0.36 0.53 
0.90 0.09 0.28 0.29 
Seven dogs C I to 7) were studied at rest or after dipyridamole without any 
coronary instrumentation. Dogs 8 to IO had a coronary stenosis placed resulting 
in 50% 10 70% narrowing of the luminal diameter. Five dogs (I 1 to 151 were 
aubjected to regional ischemia by placement of a thrombogenic copper coil 
within the left anterior descending coronary artery, and three dogs (I6 to 18) 
were studied with Induced low flow but without regional lschemia (see text). 
* indicates that a value of flow could not be computed because myocardial 
count recovery was too low yielding statistically inaccurate count data. F,, 
and F,, refer to the myocardial recovery coeficient and the blood to 
myocardial spillover fraction, respectively. REG refers to the analyzed myo- 
cardial region of interest (normal (Norm) or abnormal (Abn) in the territory of 
the left anterior descending coronary artery). SCAN indicates whether studies 
were done at rest, after dipyridamole (Dipyr) or with low flow without ischemia. 
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Figure 5. Histogram displaying myocardial recovery coefficient 
(FM& blood to myocardial spillover (F&, myocardial blood flow 
estimated by positron emission tomography (MBF-PET) or by 
microspheres (MBF-MS) in normal regions at rest or after dipyri- 
damole and in ischemic regions in four dogs with coronary occlusion 
(Dogs 12, 13, I4 and 15; Table 1) compared with estimates obtained 
in three dogs with global low flow (Dogs 16, I7 and 18; Table I). In 
four dogs with coronary occlusion, myocardial blood flow could not 
be estimated with positron emission tomography because of low 
observed counts (related to wall thinning and decreased myocardial 
count recovery as well as to low flow in itself) resulting in data too 
statistically inaccurate to make valid estimates of flow with the three 
parameter model. Note that F,, in the ischemic regions was 
significantly lower than F,, in normal myocardium. Estimates of 
low flow in dogs with global low flow were accurate. In these dogs, 
because regional ischemia did not result in wall thinning, F,, was 
preserved and permitted adequate count recovery despite low flow. 
We previously showed (2) that H2”0 provided accurate 
estimates of myocardial blood flow over a wide range of 
flows with the one-compartment Kety model when the input 
function and tissue activity were assayed directly. The 
results of the present study indicate that absolute blood flow 
can be measured accurately with positron emission tomog- 
raphy after intravenous administration of H,“O with a novel 
parameter estimation technique that incorporates a correc- 
tion for factors (including partial volume. spillover and 
motion effects) that can otherwise cause disparities between 
observed radiotracer concentration evident in reconstructed 
images and true radiotracer concentration in tissue. Results 
of validation studies in dogs indicated that flow calculated 
with positron emission tomography over a wide range of 
flows correlated very closely with flow measured concomi- 
tantly with microspheres. In human subjects, flow determi- 
nations at rest and after dipyridamole yielded values similar 
to those observed by others with invasive techniques 
(37,38). 
Technical considerations. Blood to myocardium spillover 
activity. After intravenous administration of H,“O, radio- 
activity in the blood pool is initially high. Activity spills over 
from blood into the myocardium resulting in elevation of 
observed tissue counts. With time, activity in the blood 
diminishes and apparent activity in myocardium attributable 
f 3500i n - ‘C. . . . . = CT (Observed1 - - - = CT IObserved, fitted, r 2000 - =CT (CorrectedI 8 1500 
0 IO 20 30 40 50 60 70 80 90 
TIMEhc) 
??*** =CT IObserved 
--- ‘CT IObserved, f~tfed) 
- i CT I Corrected) 
0 IO 20 30 40 50 60 m 80 90 
TIME(sec) 
Figure 6. Representation of time-activity data obtained in one 
myocardial region in a representative human study at rest (A) and 
after intravenous dipyridamole (B). The data presented are analo- 
gous to that in Figure 3 and represent the data obtained in a 
myocardial region of interest after intravenous administration of 
H,‘50. The input function (C,) was obtained from a region of 
interest placed in the left atrial blood pool. In this subject, calculated 
myocardial blood flow at rest was 0.69 ml/g per min and increased to 
3.33 ml/g per min after dipyridamole. 
to spillover decreases, whereas true myocardial counts 
increase because of tracer diffusing into tissue (Fig. 3 and 6). 
This results in spillover of activity in myocardium to activity 
detected in the chamber. Because of the relative sizes of 
these structures, spillover from the ventricular cavity to the 
myocardial tissue (F,,) is large, whereas spillover from 
tissue to cavity (FMB) is small. In addition, recovery of 
radioactivity is high in the left ventricular chamber and lower 
in the myocardial tissue (21). As depicted by the data in 
Figure 2, in human subjects, the time-activity curve in 
arterial blood can be obtained accurately from measurement 
of radioactivity from a region of interest in the left atrium in 
reconstructed tomographic scans. Estimates of the input 
function obtained noninvasively from blood pool regions in 
smaller hearts (i.e., from children or experimental animals 
such as dogs) exhibit lower recovery coefficients and greater 
bidirectional spillover. These errors in measurement of input 
function in small hearts should decrease as the resolution of 
future tomographs improve. 
Partial volume andspillover effects. With use of currently 
available tomographs for quantitation of radiotracer concen- 
tration, observed data must be corrected for partial volume, 
spillover and motion effects (I, 18-23). Previous studies have 
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Table 2. Myocardial Blood Flow Determined With Use of Positron Emission Tomography and H,“O in 11 Normal Human Subjects 
SubJeCt 
I 
2 
3 
4 
5 
6 
7 
8 
9 
IU 
II 
Age (yr) 
& 
Gender 
26 F 
23 M 
25 M 
20 M 
22 M 
28 F 
26 M 
34 F 
28 F 
24 F 
24 F 
” MBF 
6 0.67 2 0.27 
6 1.03 f 0.48 
4 0.69 2 0.26 
6 1.38 r 0.23 
6 0.78 + 0.35 
6 1.08 + 0.30 
6 1.17 ? 0.44 
3 0.90 z 0.26 
3 0.81 k 0.39 
3 0.77 i 0.22 
3 0.67 r 0.16 
Baseline 
F&W 
0.74 f 0.23 
0.47 + 0.17 
0.75 5 0.18 
0.69 ? 0.10 
0.70 * 0.09 
0.54 + 0.15 
0.56 f 0.16 
0.44 c 0.05 
0.76 f 0.32 
0.79 -t 0.18 
0.51 ? 0.05 
F BM 
0.26 k 0.07 
0.37 ? 0.18 
0.20 ? 0.03 
0.23 2 0.06 
0.28 k 0.05 
0.26 ? 0.09 
0.30 ? 0.08 
0.33 + 0.14 
0.33 + 0.07 
0.36 -c 0.09 
0.26 + 0.09 
After Dtpyridamole 
MBF F MM F BM 
3.61 f 0.54 0.62 = 0.1 I 0.37 k 0.17 
3.20 + 0.68 0.62 ‘- 0.28 0.30 k 0.14 
3.33 ? 0.47 0.68 k 0.14 0.24 ? 0.06 
4.75 + 1.40 0.34 t 0.16 0.42 2 0.24 
3.21 f 2.04 0.39 2 0.05 0.43 k 0.12 
6.02 k 1.41 0.74 i 0.12 0.15 k 0.20 
1.40 -c 0.47 0.69 2 0.12 0.27 2 0.14 
4.13 2 1.63 0.15 ? 0.13 0.47 ? 0.20 
2.91 2 0.33 0.25 k 0.03 0.48 ? 0.17 
4.00 i 0.81 0.54 t 0.07 0.23 + 0.09 
2.48 2 1.11 0.47 i- 0.12 0.35 k 0.09 
Average 0.90 f 0.22 0.63 t 0.12 0.29 f 0.05 3.55 f 1.15 0.50 i 0.19 0.34 i 0.10 
Tabulation of myocardial blood flow (MBFI in the 11 consecutively studied human volunteers under baseline conditions and after intravenous administration 
of dipyridamole. F,, and F,, = the myocardial recovery coefficient and the blood to myocardial spillover fraction, respectively; n = the total number of regions 
evaluated. Values are mean values ? SD 
employed cavitary and wall thickness measurements ob- 
tained in vivo with echocardiography, or measurements 
obtained postmortem in experimental animals to correct for 
resolution limitations (21). However, use of these measure- 
ments can lead to error because they assess anatomic 
relations in a different plane from that used for interrogation 
with positron emission tomography. Modest errors in wail 
thickness assignments (i.e., 2 to 4 mm ) can result in 
significant errors in estimates of radiotracer concentration 
and thus of flow (Fig. 9). Although we demonstrated that 
incorporation of such partial volume and spillover measure- 
ments can be used to quantify myocardial blood flow in 
Figure 7. Representation of myocardial blood flow estimated at rest 
and after administration of dipyridamole in all 11 human volunteers 
studied. As depicted, myocardial blood flow at rest averaged 0.90 * 
0.22 ml/g per min. After dipyridamole, the flow response was 
variable, but increased to an average of 3.55 k 1.15 ml/g per min, 
corresponding to a perfusion reserve of 4.1 2 1.2. 
absolute terms (22), in the present study, we developed and 
implemented a parameter fitting technique that accounts for 
factors such as partial volume, spillover and motion effects 
that cause observed data to vary from true concentrations. 
Its use obviates the need for independent measures of cavity 
radius and wall thickness and reduces error that might 
otherwise be introduced by making such dimensional assign- 
ments with an independent modality or by using “lumped” 
data. Because the estimates utilize information obtained at 
the time that data acquisition for Row is made, they avoid 
error that might otherwise be introduced by obtaining dimen- 
sional measurements at times different from those at which 
emission data are collected. 
Figure 8. Regional myocardial blood flow at rest and after intrave- 
nous dipyridamole in the 11 normal human subjects showing re- 
gional homogeneity of flow at rest and homogeneous increases in 
flow with pharmacologic coronary vasodilation. The coefficient of 
variation in individuals averaged 35 +- 10% at rest and 29 f IO% 
after dipyridamole. 
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Figure 9. Computer stimulation of estimates of error of tracer 
radioactivity that would occur if measurement of either wall diam- 
eter (D) or ventricular cavity radius (R) are inaccurate with use of 
the approach proposed by Henze et al. (21). For this analysis, a 
model with a radius of 20 mm and a wall thickness of 12 mm was 
used, approximating human heart measurements. Profiles were 
calculated for a range of “true” wall thicknesses and ventricular 
diameters and percent error of the anulus counts in the reference 
profile from “true” were computed. Errors in estimates of wall 
diameter have a much greater effect on assessment of myocardial 
tracer concentration than do errors in ventricular diameter. For 
instance, use of a wall diameter of IO mm rather than a “true” 
diameter of 12 mm (ventricular radius held constant) would result in 
an overestimate of tracer concentration within the wall of approxi- 
mately 20%, indicating the significant error that would occur if 
independent measurements of(D) were in error. 
In addition, use of the proposed technique obviates the 
need to assess blood volume and blood to tissue spillover 
with a second emission scan using Cl50 as suggested re- 
cently by Iida et al. (23). Use of a Cl50 scan to estimate 
blood volume and blood to myocardial spillover can, in 
itself, induce error in flow quantitation (24) and patient 
movement between scans can severely effect results. In the 
present study, we used a scan obtained after inhalation of 
C”O solely for identification of regions of interest within the 
blood pool. The results of the present study demonstrate 
that, in experimental animals, myocardial blood flow calcu- 
lated with this technique gives flow values that closely 
correlate with those obtained directly with radiolabeled 
microspheres over a wide range of flows. Estimates of 
myocardial blood flow in human subjects with the proposed 
techniques yielded values of blood flow at rest and after 
dipyridamole that were similar to values obtained by others 
using invasive techniques (37-39). 
Motion artifacts. An additional source of error in mea- 
surements of tracer concentration with positron emission 
tomography is motion artifact. We (19) and others (18) have 
demonstrated that cardiac motion (systoleldiastole) as well 
as cardiac motion from respiration degrade quantitative infor- 
mation obtained with positron emission tomography. Correc- 
tion schemes such as ECG or respiratory gating, or both, have 
been proposed to correct for these motion-induced artifacts 
(18,19). However, measurements of myocardial blood flow 
with dynamic scanning would be severely limited by use of 
respiratory or cardiac gating because they decreased the 
amount of useful information obtainable, thereby decreasing 
signal to noise ratios. In addition, the necessity for ECG 
gating has not been definatively established. Wisenberg et al. 
(40) demonstrated that estimates of myocardial blood flow 
obtained with and without gating were similar although ECG 
gating did diminish variance from the regression line. The 
parameter estimation procedure developed obviates the need 
for gating because the model-calculated myocardial count 
recovery coefficient (FMM) and spillover of radioactivity from 
cavity to myocardium (FBM) include linear motion effects as 
well as any other factors that would otherwise make observed 
positron emission tomography counts deviate from true ra- 
diotracer concentration. 
Low flow values from ischemic tissue. In four dogs the 
procedure could not yield a flow value from ischemic tissue. 
The low F,, in these regions indicated that the recovery 
coefficient of counts was very low, most likely reflecting wall 
thinning due to regional ischemia (34). Low recovery of 
counts, coupled with diminished counts due to low flow in 
itself and spillover of radioactivity from adjacent myocardial 
regions with normal flow, made the statistical information 
too poor for estimation of three parameters with accuracy. 
Results obtained in studies in which low flow was induced 
without wall thinning demonstrated that accurate estimates 
of flow could be obtained with the approach developed, 
documenting the validity of the mathematical model in itself 
and corroborating results of our earlier study in which low 
flow was measured accurately when tissue radioactivity was 
measured directly (2). In each case in which we were not 
able to quantitate flow in ischemic regions, the F,, was 
markedly diminished (Fig. 5). In all cases: the reconstructed 
image permitted visual identification of the ischemic region, 
as has been demonstrated previously (2,lC17). Therefore, 
clinically, although one would know that a region was 
ischemic, in some cases, an absolute flow value might not be 
able to be computed. This limitation applies not only to the 
use of H,“O, but also to use of any flow-dependent tracer, 
and should be obviated by improved instrumentation with 
better spatial resolution in conjunction with additional math- 
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ematical approaches to correct for count spillover from adja- 
cent regions. Clearly, until this can be done, the approach is 
most accurate in regions with normal or hyperemic flows. 
Variable bloodjlow response to dipyridamole. Although 
we did not measure myocardial blood flow directly by a 
second technique in our studies in human subjects, the flow 
values at rest and after dipyridamole obtained with the 
technique developed agree quite closely with results of 
others using invasive techniques (37-39). In 10 of the II 
normal subjects, intravenous dipyridamole resulted in a 
large increase in myocardial blood flow. One subject did not 
have a myocardial blood flow response to dipyridamole. 
Variability in the blood flow response to dipyridamole has 
been previously reported (37-39). 
Advantages of Hz”0 as a tracer of myocardial blood flow. 
Water, as compared with other proposed positron emitting 
flow tracers such as ammonia and rubidium, is relatively 
freely diffusible in the myocardium (2). The short life of 
oxygen-15 (2.1 min) allows rapid sequential measurements of 
flow, and the diffusibility characteristics of H,“O permit 
acquisition of accurate flow estimates over a wide range of 
flow and metabolic conditions. The short physical half-life of 
oxygen-15 limits radiation exposure. Whole body radiation 
exposure for a study at rest and after dipyridamole in human 
subjects is approximately 270 mrem/70 kg compared with an 
exposure of 360 mreml70 kg for a single conventional thal- 
lium-201 study. 
In contrast to the diffusibility of H,“O, the two other 
tracers that have been used for measurement of flow with 
positron emission tomography, rubidium-82 and N-13 am- 
monia, require functionally intact cell membrane systems for 
transport of tracer into myocardium and intracellular pro- 
cesses for trapping (I ,4-12). It has been demonstrated (4,9- 
12) that both of these processes may be affected by ischemia 
or reperfusion resulting in error in flow estimates if the 
variables of extraction fraction and myocardial washout are 
not included in quantitative estimates of flow. Quantitation 
of myocardial blood flow in absolute terms in human sub- 
jects has not been delineated with either tracer. 
Although implementation of partial volume and spillover 
corrections or incorporation of the parameter estimation 
procedure developed in this study adds computational time 
and adds to the complexity of imaging, its use permits 
application of positron emission tomography to clinical 
research requiring measurement of perfusion in absolute 
terms. The disadvantages of using H,“O are the necessity 
for an on-site cyclotron for produ&on and the need for 
tomographs with high count and temporal resolution capa- 
bilities for collection of dynamic data. Estimates of myocar- 
dial blood flow with H,150 with equilibrium scans are 
insensitive to changes in flow (41). 
Clinical implications. The results of the study indicate 
that, with the approach developed, positron emission tomog- 
raphy with Hz”0 provides rapidly attainable, accurate esti- 
mates of myocardial blood flow in absolute terms. The 
approach developed is rapid (a typical rest and dipyridamole 
study including collection of attenuation data can be per- 
formed in <I h) and provides quantitative estimates of 
myocardial blood flow. Although estimates of myocardial 
blood flow in absolute terms in ischemic zones may be 
limited by the low number of true counts and by wall 
thinning, improved instrumentation with enhanced spatial 
resolution and sensitivity as well as additional mathematical 
approaches to correct for count spillover from adjacent, 
normal regions may permit improvement of the ability to 
quantitate flow in ischemic regions. The use of the positron 
emission tomograph in human subjects should permit reso- 
lution of several critical clinical questions requiring accurate 
estimation of myocardial flow reserve in patients with car- 
diac disease of diverse origins and rapid assessment of the 
efficacy of pharmacologic, mechanical and surgical interven- 
tions designed to augment nutritional blood flow. 
We thank the personnel of the Washington University Cyclotron for prepa- 
ration of the positron emitting radiotracers used in this study: Howard James, 
Theron Baird, Colleen Schaab. RN and C. Gregory Henes, MD for technical 
assistance: Burton E. Sobel. MD, Edward M. G&man, MD and Michel M. 
Ter-Pogossian. PhD for helpful discussions; and Becky Parrack for prepara- 
tion of the typescript. 
Appendix 
Assumptions underlying the use of the one-compartment Kety 
model for estimates of myocardial blood flow. With the development 
of positron emission tomographic instruments with rapid data ac- 
quisition capabilities, application of the approach originally de- 
scribed by Kety (31-33) became feasible. Scans are performed over 
many seconds and the tissue radioactivity detected represents the 
integrated sum of radioactivity over time. Tracer activity in arterial 
blood can be determined by sampling arterial blood directly or by 
assessing tracer activity in the cardiac chamber. 
Several assumptions underlie the use of the one-compartment 
model for the measurement of myocardial bloodf7ow including: I) 
the uptake of tracer into tissue is flow dependent and not diffusion 
limited, 2) no arteriovenous shunts or bypasses are present, 3) the 
solubility of tracer must be constant, and 4) the flow must be 
constant and homogeneous throughout the sampled myocardial 
region interrogated (l-3,30-32). 
We previously demonstrated (2) that the limitation of free 
diffusibility of water in myocardium is modest, constant and not 
altered by changes in flow. Exclusion of shunts or bypasses is 
probably a valid assumption for the heart (42). However, whereas 
distribution of a diffusible tracer such as water or butanol may differ 
from the distribution of microspheres and shunting cannot be 
excluded with certainty, the single pass diffusion of H2150 was 
found to be invariant over a wide range of flow (2). In addition, 
measurements of nutritional perfusion with diffusible tracers may 
represent a more valid estimate of flow than that obtained with inert, 
carbonized microspheres (43). The assumption that flow is uniform 
in a region is likely to hold when small regions of interest are 
evaluated. It is clearly not valid for the heart as a whole. If the 
necessary assumptions are met or approximated, regional flow can 
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be determined by monitoring the arterial concentration of tracer and 
the concentration of tracer in tissue. 
Theoretical and mathematical basis of the method. For an inert, 
diffusible tracer, conservation of mass exists such that the rate of 
change in concentration of tracer in the tissue is equal to the rate of 
tracer entering the tissue minus the rate of tracer leaving the tissue 
with respect to tissue volume. Therefore: 
dC&)/dt = ; (C,(t) - C,(t)). 
where CT = tissue tracer concentration (counts per gram): F/V = 
flow per unit of tissue volume (milliliters per gram per minute); C, = 
arterial concentration of tracer (counts per milliliter); and C, = 
venous concentration of tracer (counts per milliliter). 
Kety described the relation of venous concentration of tracer to 
the tissue concentration of tracer assuming equilibration of tracer 
between blood and tissue during a single capillary passage of tracer: 
(C, - C,) = m(C, - C&J, 121 
where A = tissue/blood partition coefficient (milliliters per gram); 
and m = a diffusion constant reflecting effects of diffusion limitations 
and all other factors tending to limit equilibration of tracer between 
tissue and blood and defined as: 
m = 1 - e(-B/F). I31 
where PS is the product of capillary permeability and surface area 
(ml/g per min). For studies of H,‘*O in myocardium, A = 0.92 ml/g 
(2) and m = 1.0. Substituting (2) into (1): 
Then, solving (4): 
CT(t) = ; C,(t) * exp -; ( 
i i 
151 
where * represents convolution. 
Because current generations of positron emission tomographic 
scanners cannot measure instantaneous tissue activity, scans are 
performed over many seconds summing the decay events occurring 
during the scan: 
El 
Averaged counts over short scan intervals (i.e., 5 s) are used to 
approximate instantaneous count rates. FN (flow per unit volume) 
can be estimated by minimizing the sum of squared deviations with 
respect to F/V given that A is known and C,(t) and C,(t) can be 
measured. 
where C,.?,,(t) = observed tissue activity (counts per gram); C,(t) = 
true tissue activity (counts per gram); C&t) = observed blood 
pool activity (counts per gram): C,(t) = true blood pool activity 
(counts per gram); F,, = recovery coefficient of tissue; F,, = 
fraction of blood activity into tissue; F,, = recovery coefficient of 
blood pool: and F,, = fraction of tissue activity into blood pool. 
These corrections imply that the recovery coeficients and spill- 
A least squares technique was used for fitting equation 6 to all 
data values in the interval from 0 to 90 s after the appearance of 
tracer in the left atrium (or in directly sampled arterial blood in 
experimental animals). Therefore, estimates of F/V reflect both 
wash-in and washout processes. The optimal value of F/V is 
obtained by a direct search over the entire range of values. 
over factors are known accurately. We previously demonstrated 
that these fractions can be calculated analytically if the resolution of 
the tomograph as well as the blood pool and cardiac tissue dimen- 
sions are known and if there is no motion present (22). However, 
when cardiac and respiratory motion is present or when inaccurate 
estimates of blood pool and tissue dimensions are used, or both, 
correction fractions may be inaccurate and consequently the cor- 
rection of observed positron emission tomography counts are in- 
valid and can result in substantial error (Fig. 9). 
The 90 s time interval was selected because the actual number of To circumveni the problem of having to estimate correction 
counts in a region after this interval is very small and extending the fractions with independenr assessments of chamber and wall dimen- 
scan time results in addition of low signal-to-noise data. In addition, sions. we have incorporated within the flow model the relation 
simulation studies show that the early part of the curve is most 
sensitive to values of flow (Fig. 10). 
between true tissue counts and observed positron emission tomo- 
graphic tissue counts expressed in equation 7. 
TIME (set) 
Figure 10. Computer simulation of myocardial time-activity curves 
(with use of a single arterial input function) for flows from 0.2 to 4.0 
ml/g per min. In the approach developed, data were used from the 
time of appearance of tracer in the left atrium for 90 s. The 90 s time 
point was selected because of decreased statistical confidence in 
counts obtained after this interval, and because the early part of the 
curve is most sensitive to values of flow. 
Correction of observed counts for effects of motion and of resolution 
limitation. Because of the limited resolution of the present generation 
of tomographs in relation to the thickness of myocardium and effects 
of cardiac motion, true tissue radiotracer concentration cannot be 
measured directly with positron emission tomography. However, 
observed positron emission tomographic tissue and blood pool activ- 
ity can be related to true tissue and blood pool tracer concentration by 
correcting for partial volume and spillover effects: 
C,,,,(t) = F,, x C,(t) + F,, C,(t) 171 
C&t) = F,, x C,(t) f F,, x C,(t). Bl 
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The operational equation is thus: 
Cq,,$, : t2) = ” C,,,,(t) dt = FM,., x 
[;~;Ca~t~*.., (“;l) ,,]+,.,,lc.,,dt. 191 
where the observed positron emission tomographic tissue activity 
can now be fitted directly to the operational flow equation to 
estimate myocardial blood flow per unit volume (F/V) as well as 
F,, and F,, using a nonlinear least squares fitting routine. The 
optimal value of F/V is obtained by a direct search over the entire 
range of possible flow values with values of F,, and F,, estimated 
for each value of FN by linear, least squares approximation. The 
optimal set of parameters is then the set that minimizes the sum of 
squared deviations. By including the tissue activity correction for 
partial volume and spillover effects within the estimation of F/V, no 
a priori knowledge of F,, and F,, is needed, and consequently no 
error in its calculation is introduced in accurate correction factors. 
Furthermore, because equation 9 represents the empirical relation 
between true tissue activity and observed positron emission tomo- 
graphic tissue activity, the parameter estimated correction fraction? 
F MM and FaM include effects of linear cardiac and respiratory 
motion on observed positron emission tomographic counts. The 
model assumes that C,(t) is true (i.e., F,, = 1.0 and F,, = 0) and 
consequently that C,(t) can be obtained directly from observed 
positron emission tomography counts or that it is obtained by direct 
arterial sampling. 
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